Sumitomo Seika Chemicals (4008) Q1 2026 earnings summary

Executive summary

• Net sales for the three months ended June 30, 2025, were ¥35,569 million, down 3.6% year-over-year; operating profit fell 19.6% to ¥2,340 million; ordinary profit dropped 54.8% to ¥1,607 million; profit attributable to owners declined 58.5% to ¥1,045 million.

• Basic earnings per share decreased to ¥79.76 from ¥189.61 year-over-year; ROE was 1.1%.

Financial highlights

• Gross profit for the quarter was ¥7,468 million, down from ¥7,766 million year-over-year.

• Comprehensive income for the quarter was ¥1,260 million, a 75.3% decrease year-over-year.

• Equity-to-asset ratio stood at 66.7% as of June 30, 2025.

Outlook and guidance

• Full-year FY2025 forecast: net sales ¥145,000 million (down 1.7% YoY), operating profit ¥9,000 million (down 16.0%), ordinary profit ¥9,200 million (down 17.2%), profit attributable to owners ¥6,700 million (up 12.4%), EPS ¥506.45.

• No change to previously announced forecasts; profit growth expected due to absence of prior year extraordinary losses.